POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.

Colorado Bill Prohibits False Claims About Prescription Drug Sourcing Programs and Requires Cost Disclosures

Original title: Prescription Drug Benefit Information Transparency

Last action · February 17, 2026: House Committee on Health & Human Services Postpone IndefinitelySponsor: Ken DeGraaf

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

The measure prohibits pharmacy benefit managers and health-care consultants from knowingly spreading false statements to s regarding the legality or safety of lawful prescription drug optimized sourcing programs. It also requires them to disclose detailed drug cost information upon an employer's written request.

Why it matters

s gaining access to itemized prescription drug costs and protection from misleading claims can alter how health benefit plans negotiate and contract for pharmacy services.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Self-insured employers

Self-insured employers gain the right to request itemized prescription drug cost information and protection against misleading claims regarding sourcing programs.

Directly affected

Pharmacy benefit managers

Pharmacy benefit managers face new restrictions on statements regarding drug sourcing programs and mandatory disclosure requirements upon written request.

Directly affected

Health-care consultants

Health-care consultants are prohibited from spreading misleading claims about optimized sourcing and are subject to disclosure rules.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What are pharmacy benefit managers prohibited from doing under this bill?
They are prohibited from knowingly making or disseminating false or misleading statements or claims to s or policyholders about the legality or safety of a lawful prescription drug optimized sourcing program.
What information must be provided to a self-insured employer upon request?
Upon written request, a pharmacy benefit manager or health-care consultant must provide certain cost information for each prescription drug dispensed under the health benefit plan.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

2 actions
  1. Feb 17, 2026House
    House Committee on Health & Human Services Postpone Indefinitely
  2. Jan 14, 2026HouseIntroduced
    Introduced In House - Assigned to Health & Human Services

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Voting Record

Motion succeededHouse2/17/2026Open StatesOfficial roll call ↗

Postpone House Bill 26-1056 indefinitely using a reversal of the previous roll call. There was no objection to the use of the reverse roll call, therefore, the bill was postponed indefinitely.

Total

8

Yes
5
No
2
Present
0
Not voting
0
Abstain
0
Other positions
1
Show 1 earlier roll call

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

Prescription Drug Optimized Sourcing Transparency and Integrity Act

Sources

Open source document

leg.colorado.gov

Analysis Score

0–100
  • Significance60
    How much this matters to a regular citizen
  • Controversy50
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record